Vivek Das/LinkedIn
Jul 31, 2026, 07:54
Vivek Das: From Inflammation to Integrated Precision Cardiovascular Care
Vivek Das, Lead Data Scientist at Novo Nordisk, shared a post on LinkedIn:
“A timely review from the European Society of Cardiology highlights an important direction for precision cardiovascular medicine.
While inflammation remains a key driver of coronary artery disease, meaningful progress will increasingly depend on integrating biomarkers, imaging, multi-omics, and clinical evidence to better understand residual risk and support more individualized care.
Equally important, translating these advances into practice will require robust evidence, careful validation, and thoughtful implementation.
An insightful read for anyone interested in the future of biomarkers and precision medicine.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?
-
Sep 20, 2026, 04:34Hons Saurabh Kaushik: Why Uncontrolled LDL Can Be Harmful
-
Sep 20, 2026, 03:58Salih Ehsan: The Complexities of HbF and HbA2
-
Sep 20, 2026, 03:22The Voices of People Living With Bleeding Disorders – EHC